Health 2.0 Europe 2011 is Accepting Speaker Submissions

Following the success of the first event in Paris in April 2010, the 2nd annual Health 2.0 Europe will showcase the best of Europe's user-generated healthcare and reconvene over 500 leaders and stakeholders in Web 2.0 for health. Participants will include IT solution providers, health professionals, patient organizations, health authorities, public and private insurance organizations, medical device and pharmaceutical companies, telecom groups, VC and financiers, policy makers, and academics.

If you are in the Health 2.0 space and offer a technology or service that is particularly innovative or provides a solution to a major healthcare challenge, Health 2.0 wants to hear from you! In general, most of the programming consists of panels with speakers showing their technology in 4-minute demos, and commentators reflecting on what they hear and how it will fit into healthcare from their perspective, followed by interaction with the demonstrators.

Themes for 2011 will include:

  • Patient and physician social networks
  • Search & content
  • Communities and data production
  • Consumer and provider tools
  • Health promotion, behavior change and Wellness 2.0
  • Data utility layer & tools
  • System integration
  • Health 2.0 financing
  • Cloud computing and unplatforms

More information on the programme is available at http://www.health2con.com/europe/.

Decisions on panelists are made by the organizers in close consultation with our Advisory Board. It is a highly selective process as the topic of the conference, audience interest, diversity of presenters and format of panels are taken into consideration.

Apply now!

Most Popular Now

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Sandoz Healthcare Access Challenge #SandozHACk ret…

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global co...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

Novartis licenses three novel anti-infective progr…

Novartis announced today that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug cand...

The Nobel Prize in Physiology or Medicine 2018 was…

Cancer kills millions of people every year and is one of humanity's greatest health challenges. By stimulating the inherent ability of our immune system to attack tumor c...

Pfizer to award more than $3 million in grants to …

Pfizer Inc. today announced the recipients of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Breast Cancer Research Awards. Four grants tota...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

DNA islands effective as 'anti-bacterial drones'

Genomic "islands" that evolved from viruses can be converted into "drones" that disable Staphylococcus aureus, bacteria that are often resistant to antibiotics and pose a...

FDA awards 12 grants to fund new clinical trials t…

The U.S. Food and Drug Administration today announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to...

Addressing social and cultural drivers of type 2 d…

New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and ...

Evidence mounts linking aspirin to lower risk of o…

Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer. A new study co-led by Moffitt Cancer Center found that women who reported ta...